Drugs / jinghua weikang capsule
jinghua weikang capsule
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06056973 | Oct 2023 → Oct 2025 | esophagitis | The First Affiliated Hospital of Dalian Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | jinghua weikang capsule | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06056973 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “The main efficacy of Jinghua Weikang capsules is regulating qi and dispersing cold, clearing heat and removing blood stasis.” NCT06056973 ↗ |
| Route | Oral | “Oral Jinghua Weikang Capsule, two capsules each time, three times a day” NCT06056973 ↗ |